Hematology

The ASAP trial shows immediate transplantation matches chemotherapy outcomes in AML, with genetics driving survival differences.

Researchers identify P-selectin as key driver of blood stem cell ageing and inflammation-linked decline.

Serum-free light chain testing enables earlier, more accurate tracking of multiple myeloma treatment response and disease progression.

Delays between cell collection and infusion significantly lower survival rates for lymphoma patients receiving CAR T-cell therapy.

Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.

Gene-editing therapy exa-cel dramatically improved pain and quality of life in sickle cell disease.

A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure risk, highlighting the need for enhanced cardiac monitoring.

New study develops accurate predictive model identifying key factors for anaemia in elderly patients, aiding early detection and management.